 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/11/2024 |
$8.04 |
$8.11 |
$7.90 |
$8.01 |
2.38M | | 04/12/2024 |
$8.00 |
$8.08 |
$7.83 |
$7.88 |
2.78M | | 04/15/2024 |
$7.90 |
$7.93 |
$7.71 |
$7.79 |
2.86M | | 04/16/2024 |
$7.75 |
$7.93 |
$7.68 |
$7.89 |
2.07M | | 04/17/2024 |
$7.94 |
$7.94 |
$7.64 |
$7.65 |
2.40M |
|
|
| Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing the treatment of GI diseases. Co. is focused on the development and commercialization of GI product opportunities. LINZESS® (linaclotide), Co.'s commercial product, is a product approved by the U.S. Food and Drug Administration in a class of GI medicines called guanylate cyclase type C agonists and is indicated for adult suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation. Co. is also developing IW-3300, a GC-C agonist, for the potential treatment of visceral pain conditions, including interstitial cystitis / bladder pain syndrome and endometriosis. | |
|
Ironwood Pharmaceuticals (IRWD) has the following price history information. Looking back at IRWD historical stock prices for the last five trading days, on April 11, 2024, IRWD opened at $8.04, traded as high as $8.11 and as low as $7.90, and closed at $8.01. Trading volume was a total of 2.38M shares. On April 12, 2024, IRWD opened at $8.00, traded as high as $8.08 and as low as $7.83, and closed at $7.88. Trading volume was a total of 2.78M shares. On April 15, 2024, IRWD opened at $7.90, traded as high as $7.93 and as low as $7.71, and closed at $7.79. Trading volume was a total of 2.86M shares. On April 16, 2024, IRWD opened at $7.75, traded as high as $7.93 and as low as $7.68, and closed at $7.89. Trading volume was a total of 2.07M shares. On April 17, 2024, IRWD opened at $7.94, traded as high as $7.94 and as low as $7.64, and closed at $7.65. Trading volume was a total of 2.40M shares.
IRWD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ironwood Pharmaceuticals shares, starting with a $10,000 purchase of IRWD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/17/2024 |
|
| Start price/share: |
$10.10 |
|
| End price/share: |
$7.65 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-24.26% |
|
| Average Annual Total Return: |
-2.74% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$7,575.46 |
|
| Years: |
9.99 |
|
|
|
| Date |
Close |
| 04/11/2024 | $8.01 | | 04/12/2024 | $7.88 | | 04/15/2024 | $7.79 | | 04/16/2024 | $7.89 | | 04/17/2024 | $7.65 |
|
|
Free IRWD Email Alerts:
